Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Multisystem Inflammatory Syndrome in Children (MIS-C) long-term follow-up
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 75N91019D00024-P00001-759102000025-4
Grant search
Key facts
Disease
COVID-19Start & end year
20202025Known Financial Commitments (USD)
$1,000,000Funder
National Institutes of Health (NIH)Principal Investigator
GINA MONTEALEGREResearch Location
United States of AmericaLead Research Institution
LEIDOS BIOMEDICAL RESEARCH, INC.Research Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Post acute and long term health consequencesSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
Adolescent (13 years to 17 years), Adults (18 and older)…Vulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
This is a multisite prospective observational study to evaluate the clinical sequelae of symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the pediatric population (aged 0-21 years), including coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C).